| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.406 | 0 | 0 | 0 | 585 | 4.686 | 2.010 | 2.390 | 2.269 | 183 |
| Total Income - EUR | 49.406 | 0 | 0 | 0 | 585 | 4.686 | 2.010 | 3.168 | 2.267 | 96 |
| Total Expenses - EUR | 18.956 | 0 | 178 | 128 | 621 | 4.610 | 5.441 | 3.424 | 2.046 | 414 |
| Gross Profit/Loss - EUR | 30.449 | 0 | -178 | -128 | -36 | 76 | -3.431 | -256 | 221 | -317 |
| Net Profit/Loss - EUR | 28.967 | 0 | -178 | -128 | -54 | -56 | -3.491 | -320 | 186 | -317 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Q.f. Laboratories Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 111 | 110 | 108 | 106 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 63.492 | 62.845 | 61.685 | 60.553 | 59.412 | 61.199 | 53.818 | 54.612 | 57.637 | 56.993 |
| Inventories | 9.310 | 9.215 | 9.059 | 8.893 | 8.779 | 7.780 | 7.653 | 8.991 | 8.715 | 8.819 |
| Receivables | 52.957 | 52.417 | 51.530 | 50.584 | 49.604 | 48.326 | 43.013 | 41.387 | 45.070 | 44.960 |
| Cash | 1.225 | 1.213 | 1.096 | 1.076 | 1.029 | 5.093 | 3.152 | 4.235 | 3.851 | 3.214 |
| Shareholders Funds | 45.971 | 45.503 | 44.555 | 43.609 | 42.711 | 41.846 | 37.427 | 37.223 | 37.296 | 36.770 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.631 | 17.452 | 17.238 | 17.049 | 16.701 | 19.353 | 16.391 | 17.389 | 20.341 | 20.223 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Q.f. Laboratories Srl